ARCHIVES

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 30 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Phase III Kyprolis Trial Fails OS Primary Endpoint

August 29, 2014

Wanted: Methods To Measure Or Estimate Renal Function For Dosing Cancer Drugs

October 15, 2010

Zerhouni Starts Work As NIH Director

May 24, 2002

NCI Summarizes AIDS Virus Developments

May 4, 1984

Gene Therapy Appears to Benefit Two Children With ADA Deficiency, Scientist Tells Writers

April 9, 1993

Abstracts Of Papers Presented By Breast Cancer Task Force

July 16, 1976